Product Code: Ab-chminaca
Availability: In Stock

Available Options

AB CHMINACA is an indazole-based manufactured cannabinoid. It is a powerful agonist of the CB1 receptor (Ki = 0.78 nM) and CB2 receptor (Ki = 0.45 nM) and completely substitutes for Δ9-THC in rodent separation thinks about, while being 16x more strong. Proceeding with the pattern seen in different cannabinoids of this age, it contains a valine amino corrosive amide buildup as a component of its structure, where more seasoned cannabinoids contained a naphthyl or adamantane deposit. 

AB CHMINACA is a logical reference standard arranged as an engineered cannabinoid. This item is expected for investigate and legal applications. 

AB CHMINACA, or N-[(2S)- 1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide, is a manufactured indazole cannabinoid tranquilize as it contains a substituted indazole center. A cyclohexylmethyl gather is bound to this indazole center at R1 of the indazole. This indazole is substituted at R3 with a carboxamide gathering. The terminal amine of this carboxamide is clung to a substituted propyl chain with an aminocarbonyl aggregate at R1 and a methyl amass at R2. 

Abdominal muscle CHMINACA (N-[(2S)- 1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide) is a medication that goes about as an intense agonist for the cannabinoid receptors which produces subjective impacts to some degree. It was created by Pfizer and unveiled in a 2009 patent as a potential pain relieving drug, yet was never sought after for human utilize.

This product is intended for research and forensic applications. Warning - this product is not for human or veterinary use.

Formal Name
CAS Number
Molecular Formula
Formula Weight
A crystalline solid
210, 303 nm
O=C(N[[email protected]](C(N)=O)C(C)C)C1=NN(CC2CCCCC2)C3=C1C=CC=C3
InChI Code
InChI Key
Warning - this product is not for human or veterinary use.

Write a review

Please login or register to review